- Home
- SHIP vs FATE Comparison
SHIP vs FATE Comparison
Compare SHIP & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHIP
- FATE
- Stock Information
- Founded
- SHIP 2008
- FATE 2007
- Country
- SHIP Greece
- FATE United States
- Employees
- SHIP N/A
- FATE N/A
- Industry
- SHIP Marine Transportation
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHIP Consumer Discretionary
- FATE Health Care
- Exchange
- SHIP Nasdaq
- FATE Nasdaq
- Market Cap
- SHIP 114.3M
- FATE 133.0M
- IPO Year
- SHIP 2007
- FATE 2013
- Fundamental
- Price
- SHIP $6.23
- FATE $1.21
- Analyst Decision
- SHIP Strong Buy
- FATE Hold
- Analyst Count
- SHIP 1
- FATE 8
- Target Price
- SHIP $11.00
- FATE $4.14
- AVG Volume (30 Days)
- SHIP 94.4K
- FATE 1.8M
- Earning Date
- SHIP 05-27-2025
- FATE 05-13-2025
- Dividend Yield
- SHIP 10.59%
- FATE N/A
- EPS Growth
- SHIP 48.17
- FATE N/A
- EPS
- SHIP 1.26
- FATE N/A
- Revenue
- SHIP $153,372,000.00
- FATE $13,335,000.00
- Revenue This Year
- SHIP N/A
- FATE N/A
- Revenue Next Year
- SHIP $21.30
- FATE N/A
- P/E Ratio
- SHIP $4.93
- FATE N/A
- Revenue Growth
- SHIP 17.53
- FATE 105.85
- 52 Week Low
- SHIP $4.78
- FATE $0.66
- 52 Week High
- SHIP $12.80
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- SHIP 57.16
- FATE 53.44
- Support Level
- SHIP $5.81
- FATE $1.12
- Resistance Level
- SHIP $6.54
- FATE $1.38
- Average True Range (ATR)
- SHIP 0.25
- FATE 0.12
- MACD
- SHIP 0.04
- FATE 0.01
- Stochastic Oscillator
- SHIP 57.53
- FATE 62.22
About SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Fellowship, Championship, Partnership, Knightship, Lordship, Gloriuship, Leadership, Geniuship, Premiership, and Squireship, among others.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.